3.3.9 Dermatofibrosarcoma protuberans

Grading & Level of Importance: C

ICD-11

2B53.Y

Synonyms

DFSP

Epidemiology

Rare tumor, but on the skin the most frequent sarcoma type, panethnic, 0.01 to 0.045:100.000/ year, male:female ratio 1:1,5, mean age around 40-50 years. Children mostly not affected.

Read more

Rare tumor, but on the skin the most frequent sarcoma type, pan-ethnic, 0.01 to 0.045:100,000/ year, less than 1% of all soft tissue sarcomas. Male: female ratio 1:1.5, mean age around 40-50 years. Children mostly not affected.

Definition

Dermatofibrosacoma protuberans ( DFSP) is a rare usually non metastizing mesenchymal malignant tumor with an undermining-infiltrative ,aggressive growth pattern and high local recurrence rate.

Aetiology & Pathogenesis

The cause of DFSP is unknown, but a traumatic initiation is discussed. A trauma has been reported in about 10-20% of cases.  In 90 % of cases a translocation of genetic material 17q22; 22q13 with fusion of genes COL1A1 and PDGFß has been detected. The gen product, a COL1A1-PDGFß- fusion protein binds to a constitutive expressed PDGF-receptor acting thereafter as an autocrine growth stimulus for DFSP-cells. It usually does not metastasize (< 1%), however, it is highly agressively growing horizontally in the sorrounding , therefore classified as G2.

Signs & Symptoms

DFSP arises from deeper layers of the dermis. Typically, at the beginning no subjective symptoms are reported. DFSP appears solitary and starts starts as a small, firm skin coloured patch and may turn into purplish, reddish, or flesh-colored and is usually without clear margins. A rare variant is pigmented. The tumor grows slowly and infiltrative horizontally and polycyclic but becomes later a plaque and / or classical derma a big node. At late stage it can exulcerate.

Localisation

It is commonly found on the trunk, usually in the shoulder and chest area.

Classification

  • Dermatofibrosarcoma protuberans, cassical type.

  • Bednar-tumor, pigmented type.

  • Myxoid type.

  • Pleomorphic – storiform type.

Read more
  • Dermatofibrosarcoma protuberans, classical type.

  • Bednar- tumor, pigmented type.

  • myxoid type.

  • pleomorphic – storiform type

  • myoid type,

  • granular cell type,

  • sclerosing type,

  • atrophic type and

  • fibrosarcomatous type

Laboratory & other workups

None specific.

Dermatopathology

The biopsy is essential to diagnose the tumor. For the diagnosis one needs a representative tart piece like biopsy, a punch biopsy is usually less helpful. By low power magnification one can see a the whole dermis infiltrating mesenchymal tumor composed of bundles of spindle cells. A fascicular and radiary growth produces the typical cartwheel pattern. Infiltrating the subcutis produces a honey comb pattern with large bundles of tumor cells sorrounding the adipose cells. By immunohistochemistry the tumor cells express the CD 34 antigen.

Read more

Biopsy is essential to diagnose the tumor. For the diagnosis one needs a representative ellipse biopsy, a punch biopsy is usually less helpful. By low power magnification one can see the whole dermis infiltrating mesenchymal tumor composed of bundles of spindle cells. A fascicular and radial growth produces the typical cartwheel pattern. Infiltration of the subcutis produces a honeycomb pattern with large bundles of tumor cells surrounding the adipose cells. By immunohistochemistry, the tumor cells express the CD 34 antigen plus tenascin, COL1A1.

Course

A regular follow-up is essential after tumor removal to monitor for recurrence. Local relapses appear in 10-20% of DFSP`s, usually within three years of the initial surgery. Despite being locally aggressive, the tumor spreads to other parts of the body (metastasizes) in only 5% of cases.

Read more

A regular follow-up is essential after tumor removal to monitor for recurrence. Local relapses appear in 10-20% of DFSP`s, usually within three years of the initial surgery. Despite being locally aggressive, the tumor spreads to other parts of the body (metastasizes) in only 5% of cases. The 10-year overall survival rate is 90.7%. The fibrosarcomatous variant (DFSP-FS) has a worse outcome with a 5-year local progression-free survival rate of 33%, only.

Complications

Infiltration with joint involement, exulceration. Scarring.

Diagnosis

Diagnosis relies on clinical features and dermpathology.

Differential Diagnosis

Prevention & Therapy

Treatment depends on size and localization. Typically, it is treated with complete wide surgical excision of > 3 cm (lowest recurrence rate of 7%); Mohs surgery or 24 hrs dermpath finding is performed dependent on localisation.

 

The chemotherapeutic agent imatinib mesylate is approved for adults with unresectable, recurrent, or metastatic dermatofibrosarcoma protuberans.

Read more

Treatment depends on size and localization. Typically, it is treated with complete wide surgical excision (lowest recurrence rate of 7% with margins ≥ 3 cm, significantly better at reducing local recurrence than margins < 3 cm margins); Mohs surgery or 24 hrs dermpath finding is performed dependent on localisation.

The chemotherapeutic agent imatinib mesylate is approved for adults with unresectable, recurrent, or metastatic dermatofibrosarcoma protuberans.

Special

None.

Comments

Be the first one to leave a comment